Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$7.84 - $12.6 $1.89 Million - $3.03 Million
-240,690 Reduced 88.23%
32,093 $285,000
Q1 2021

May 14, 2021

BUY
$10.54 - $19.3 $10,213 - $18,701
969 Added 0.36%
272,783 $3.46 Million
Q4 2020

Mar 01, 2021

SELL
$12.79 - $17.1 $318,330 - $425,601
-24,889 Reduced 8.39%
271,814 $3.79 Million
Q3 2020

Nov 13, 2020

BUY
$12.99 - $19.41 $74,302 - $111,025
5,720 Added 1.97%
296,703 $3.86 Million
Q2 2020

Aug 14, 2020

BUY
$12.19 - $22.96 $196,295 - $369,724
16,103 Added 5.86%
290,983 $5.08 Million
Q1 2020

May 15, 2020

BUY
$10.08 - $27.21 $1.05 Million - $2.84 Million
104,242 Added 61.09%
274,880 $4.28 Million
Q4 2019

Feb 14, 2020

BUY
$13.05 - $21.88 $304,913 - $511,226
23,365 Added 15.87%
170,638 $3.43 Million
Q2 2019

Aug 15, 2019

SELL
$13.21 - $27.29 $46,829 - $96,743
-3,545 Reduced 2.35%
147,273 $0
Q1 2019

May 14, 2019

SELL
$12.46 - $22.05 $33,841 - $59,887
-2,716 Reduced 1.77%
150,818 $0
Q4 2018

Feb 13, 2019

BUY
$15.43 - $32.7 $479,379 - $1.02 Million
31,068 Added 25.37%
153,534 $2.56 Million
Q3 2018

Nov 14, 2018

BUY
$26.95 - $52.7 $147,308 - $288,058
5,466 Added 4.67%
122,466 $0
Q2 2018

Aug 14, 2018

BUY
$28.08 - $31.2 $3.29 Million - $3.65 Million
117,000 New
117,000 $0

Others Institutions Holding AVRO

# of Institutions
1
Shares Held
559K
Call Options Held
0
Put Options Held
0

About AVROBIO, Inc.


  • Ticker AVRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,773,900
  • Description
  • AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...
More about AVRO
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.